INTRODUCTION
============

Pemphigus is a rare autoimmune disease of the skin and mucous membranes. Previous studies have shown that some viral infections may be triggers for autoimmune diseases in patients with genetic susceptibility to them.^[@r01]^ The role of viral infections in the etiopathogenesis of pemphigus has also been investigated.^[@r02]^ The role of HCV in the etiopathogenesis of secondary anti-phospholipid syndrome, Sjögren syndrome, autoimmune trombocytic purpura and cryoglobulinemia, have been reported.^[@r03],[@r04]^ Similarly, the mechanisms involved in HBV infection have been proposed as a trigger in some autoimmune diseases such as diabetes mellitus type 1, polyarteritis nodosa and vitiligo.^[@r05],[@r06],[@r07]^ However, there are few studies that evaluate the relationship between pemphigus and HCV and HBV infections.^[@r08]-[@r11]^ The purpose of this study is to investigate the frequency of HCV and HBV infections in our patients who had recently been diagnosed with pemphigus.

MATERIALS AND METHODS
=====================

Sixty-two patients with a new diagnosis of pemphigus were included in this retrospective study. In addition to clinical and histopathological findings, diagnosis of pemphigus had been confirmed through direct immunofluorescent microscopy. The control group was composed of 50 subjects of matching ages and genders, gathered from among the relatives of the orthopedic patients. The controls all had a negative history for systemic and/or autoimmune diseases and had provided verbal informed consent for the study. In our departments, all patients with pemphigus are screened for HBsAg, HBsAb and anti-HCV, using ELISA, before starting appropriate immunosuppressive therapy, since this treatment can exacerbate viral infections such as HBV and HCV infections. The control group was set up after the decision had been taken to conduct a retrospective study. This group was informed about viral hepatitis and the vaccination for HBV, and those who were found to be eligible for the study were included. The study used their patient records or face-to face interviews to obtain their ages, genders, serologic test results, family history of HBV and HCV occurrences and the risk factors for HBV and HCV infections, such as blood transfusion, hemodialysis, past operations, transplantation, ear piercing, dental surgery and similar trauma histories. The serological test results of pemphigus patients were acquired from the database of our patients\' records.

Statistical Analysis:
---------------------

SPSS Statistics 17.0 for Windows was used for statistical analysis. The distribution of the data was tested using Kolmogrov-Smirnov and Anova tests. The independent test was used for the analysis of the data; p\<0.05 was considered to be significant.

RESULTS
=======

The study group involved 62 pemphigus patients, including 43 women and 19 men (age range: 10-78 years, mean 48.08 ± 15.38) and 50 controls with 35 women and 15 men (age range 18-82 years, mean 48.56 ± 15.50). Of the 62 pemphigus patients, 57 (92%) had pemphigus vulgaris, 2 (3.2%) had pemphigus foliaceus, 2 (3.2%) had pemphigus vegetans and 1 (1.6%) had pemphigus erythematosus.

Anti-HCV Ab was negative in all of the pemphigus patients. Among this group, only one had a family member with HCV infection. In the control group, anti-HCV test results were found to be positive in 2 (4%) individuals who were also positive for HCV-RNA, confirming HCV infection. We did not find a statistically significant difference between the two groups for HCV infection (p=0.114) ([Table 1](#t01){ref-type="table"}). In the assessment of risk factors, only one of the HCV-positive controls declared a past surgery, but that had been more than three months before and was not interpreted as a risk factor.

###### 

The comparison of HBsAg, Anti HBsAg and Anti-HCV test results and the existence of risk factors for hepatitis virus infections between the pemphigus group and the control group

                                                                                          **Pemphigus patients**   **n**   **%**   **Control group**   **n**   **%**   **P**
  ------------------ -------------------------------------------------------------------- ------------------------ ------- ------- ------------------- ------- ------- -------
  **Anti-HCV**                                                                            Positive:                0       0       Positive:           2       4       0.114
                                                                                          Negative:                62      100     Negative:           48      96       
  **HBsAg**                                                                               Positive:                2       4.56    Positive:           1       2       0.526
                                                                                          Negative:                42      95.44   Negative:           49      98       
  **AntiHBsAg**                                                                           Positive:                14      31.8    Positive:           14      28      0.848
                                                                                          Negative:                30      68.2    Negative:           36      72       
  **Risk Factors**   Abnormality in hepatic function tests                                Yes:                     2       3.2     Yes:                3       6       0.932
                                                                                          No:                      60      96.8    No:                 47      94       
                     Hepatitis B and/ or C virus infection in family members              Yes:                     1       1.6     Yes:                0       0       0.159
                                                                                          No:                      61      98.4    No:                 50      100      
                     Past operation (operations done under local or general anesthesia)   Yes:                     14      22.6    Yes:                10      20      0.960
                                                                                          No:                      48      77.4    No:                 40      80       
                     Ear piercing                                                         Yes:                     11      17,75   Yes:                13      26      0.294
                                                                                          No:                      51      82,25   No:                 37      76       
                     Blood transfusion                                                    Yes:                     2       3.2     Yes:                1       2       0,381
                                                                                          No:                      60      96.8    No:                 49      98       
                     Hemodialysis                                                         Yes:                     0       0       Yes:                0       0       1
                                                                                          No:                      62      100     No:                 50      100      
                     Transplantation                                                      Yes:                     0       0       Yes:                0       0       1
                                                                                          No:                      62      100     No:                 50      100      
                     Blood transfusion or past operation in the last 3 months             Yes:                     0       0       Yes:                0       0       1
                                                                                          No:                      62      100     No:                 50      100      

We could only evaluate HBV screening in 44 of the 62 pemphigus patients because of temporary technical problems. Fourteen (31.8%) of the patients were HBsAb positive and 2 (4.3%) were HBsAg positive, denoting HBV infection. We did not find any of the risk factors in the two pemphigus patients with Hepatitis B infection ([Table 2](#t02){ref-type="table"}). In the control group, 14 (28%) individuals were HBsAb positive and 1 (2%) was HBsAg positive. There were no statistically significant differences between the two groups for HBsAb and HBsAg positivity (p=0.848, p=0.526, respectively) (See [Table 1](#t01){ref-type="table"}). We did not encounter any of the risk factors in the patients and controls with positive serology for HBV.

###### 

There were no risk factors in the two pemphigus patients with Hepatitis B infection

                                                                                      **Patient 1**   **Patient 2**
  -------------- -------------------------------------------------------------------- --------------- ---------------
  Risk factors   Hepatitis B infection in family members                              Absent          Absent
                 Past operation (operations done under local or general anesthesia)   Absent          Absent
                 Ear piercing                                                         Absent          Absent
                 Blood transfusion                                                    Absent          Absent
                 Hemodialysis                                                         Absent          Absent
                 Transplantation                                                      Absent          Absent
                 Blood transfusion or past operation in the last 3 months             Absent          Absent

DISCUSSION
==========

Pemphigus is an autoimmune disease characterized by painful oral mucosa erosions and fragile bullous skin lesions. The IgG-type antibodies targeting the keratinocytic antigens, desmoglein 1 and desmoglein 3, play a major role in the etiopathogenesis of the disease, by inducing acantholysis.^[@r12]^

Although there is some conflicting evidence, the hypothesis that some infections trigger autoimmune disease in genetically predisposed individuals is still up to date. The association of cryoblobulinemia and Sjögren syndrome with chronic HCV infections is well-known. Furthermore, the antinuclear, anti-smooth muscle, anticardiolipin and antithyroid antibody positivity accompanying these infections, support this view.^[@r04]^

The exact pathogenetic mechanism involved in HCV and autoimmunity is not known. However, this microorganism has been incriminated in the elimination of tolerance that is protected from autoimmunity.^[@r13]^ In addition, the activation of B lymphocytes resulting from HCV residence on these cells has been seen as responsible for autoimmunity.^[@r14]^

Some studies have investigated the association of HCV with autoimmune diseases. Agmon-Levin et al. found that the frequency of HCV infection in 1,322 patients with various autoimmune diseases was significantly higher (8.7%), compared with the control group (%0.4). In this study, the prevalence of HCV was found to be 14% among the pemphigus vulgaris patients, and the authors emphasized a new association between HCV and pemphigus.^[@r08]^ The prevalence of HBV infection in anti-HCV-positive pemphigus foliaceus patients was also found to be considerable.^[@r10]^ Sagi et al. found that the frequency of HBV, HCV, H. pylori, T. gondii, T. pallidum and CMV was significantly higher than in the control group in pemphigus and bullous pemphigoid patients.^[@r09]^ In accordance with these results, a pemphigus case has been reported after a hepatitis B vaccination.^[@r11]^ However, there are also opposing results: Rosa et al. did not find any association between HCV infection and pemphigus in 126 patients with fogo selvage, in their study group.^[@r10]^ In terms of our findings, although the prevalence of HCV infection was 4% in the control group, none of our 62 pemphigus patients had HCV infection. Nevertheless, the prevalence of HBV infection in our pemphigus patients was 4.3%, while it was 2 % in the control group. There was no statistically significant difference between the two groups for HBV and HCV infections. According to the surveys, 1% of the Turkish population has been found to be infected by HCV, and 2.7% by HBV. ^[@r15]^ The results are also slightly different from the general population. We believe that the results obtained may have been caused by the small numbers in our study groups. If the number of patients and controls were higher, the prevalence of these viral infections would probably be closer to the prevalence within the general population.

CONCLUSION
==========

The controversy surrounding the role of viral infections in the etiopathogenesis of autoimmune diseases still exists today. However, the findings of our study do not support any association between pemphigus and HBV and/or HCV infections.
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